View Future GrowthMedical Packaging 過去の業績過去 基準チェック /26Medical Packagingは、平均年間36.1%の収益成長を遂げていますが、 Packaging業界の収益は、年間 成長しています。収益は、平均年間30.6% 26%収益成長率で 成長しています。 Medical Packagingの自己資本利益率は4.7%であり、純利益率は10.6%です。主要情報36.15%収益成長率23.81%EPS成長率Packaging 業界の成長9.45%収益成長率25.99%株主資本利益率4.75%ネット・マージン10.60%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • Aug 18Second quarter 2024 earnings released: EPS: ج.م0.021 (vs ج.م0.007 in 2Q 2023)Second quarter 2024 results: EPS: ج.م0.021 (up from ج.م0.007 in 2Q 2023). Revenue: ج.م29.0m (up 72% from 2Q 2023). Net income: ج.م13.8m (up 224% from 2Q 2023). Profit margin: 48% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 143% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 07Full year 2023 earnings released: EPS: ج.م0.032 (vs ج.م0.017 in FY 2022)Full year 2023 results: EPS: ج.م0.032. Revenue: ج.م91.0m (up 54% from FY 2022). Net income: ج.م2.10m (down 63% from FY 2022). Profit margin: 2.3% (down from 9.7% in FY 2022). The decrease in margin was driven by higher expenses.Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ج.م7.00 (vs ج.م0.004 in 3Q 2021)Third quarter 2022 results: EPS: ج.م7.00 (up from ج.م0.004 in 3Q 2021). Revenue: ج.م15.5m (up 25% from 3Q 2021). Net income: ج.م2.37m (up 54% from 3Q 2021). Profit margin: 15% (up from 12% in 3Q 2021). The increase in margin was driven by higher revenue.Reported Earnings • Mar 07Full year 2020 earnings released: EPS ج.م0.01 (vs ج.م0.017 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ج.م36.7m (up 23% from FY 2019). Net income: ج.م4.41m (down 21% from FY 2019). Profit margin: 12% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesNew Risk • Jun 13New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 11% Last year net profit margin: 31% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (11% net profit margin). Revenue is less than US$5m (ج.م98m revenue, or US$1.9m). Market cap is less than US$100m (ج.م1.10b market cap, or US$21.2m).お知らせ • Jun 02Medical Packaging Company, Annual General Meeting, Jun 20, 2026Medical Packaging Company, Annual General Meeting, Jun 20, 2026, at 12:00 Egypt Standard Time. Location: cairo EgyptNew Risk • May 22New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 25% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (25% accrual ratio). Minor Risks Revenue is less than US$5m (ج.م133m revenue, or US$2.7m). Market cap is less than US$100m (ج.م831.9m market cap, or US$16.7m).お知らせ • Mar 20Medical Packaging Company, Annual General Meeting, Apr 12, 2025Medical Packaging Company, Annual General Meeting, Apr 12, 2025, at 13:00 Egypt Standard Time. Location: cairo EgyptReported Earnings • Aug 18Second quarter 2024 earnings released: EPS: ج.م0.021 (vs ج.م0.007 in 2Q 2023)Second quarter 2024 results: EPS: ج.م0.021 (up from ج.م0.007 in 2Q 2023). Revenue: ج.م29.0m (up 72% from 2Q 2023). Net income: ج.م13.8m (up 224% from 2Q 2023). Profit margin: 48% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 143% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ج.م1.30, the stock trades at a trailing P/E ratio of 64.9x. Average trailing P/E is 6x in the Packaging industry in Africa. Total returns to shareholders of 169% over the past three years.New Risk • Mar 31New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Egyptian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (2.3% net profit margin). Revenue is less than US$5m (ج.م91m revenue, or US$1.9m). Market cap is less than US$100m (ج.م1.47b market cap, or US$31.1m).Reported Earnings • Mar 07Full year 2023 earnings released: EPS: ج.م0.032 (vs ج.م0.017 in FY 2022)Full year 2023 results: EPS: ج.م0.032. Revenue: ج.م91.0m (up 54% from FY 2022). Net income: ج.م2.10m (down 63% from FY 2022). Profit margin: 2.3% (down from 9.7% in FY 2022). The decrease in margin was driven by higher expenses.Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ج.م7.00 (vs ج.م0.004 in 3Q 2021)Third quarter 2022 results: EPS: ج.م7.00 (up from ج.م0.004 in 3Q 2021). Revenue: ج.م15.5m (up 25% from 3Q 2021). Net income: ج.م2.37m (up 54% from 3Q 2021). Profit margin: 15% (up from 12% in 3Q 2021). The increase in margin was driven by higher revenue.New Risk • Nov 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2022 fiscal period end). Shareholders have been substantially diluted in the past year (90% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (ج.م53m revenue, or US$1.7m). Market cap is less than US$100m (ج.م662.9m market cap, or US$21.5m).Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 41%After last week's 41% share price gain to ج.م1.01, the stock trades at a trailing P/E ratio of 75.3x. Average trailing P/E is 8x in the Packaging industry in Africa. Total returns to shareholders of 207% over the past three years.Buying Opportunity • Oct 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be ج.م0.80, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 32% over the last year. Earnings per share has grown by 47%.New Risk • Aug 17New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended June 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2022 fiscal period end). Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (90% increase in shares outstanding). Minor Risks Revenue is less than US$5m (ج.م53m revenue, or US$1.7m). Market cap is less than US$100m (ج.م472.3m market cap, or US$15.3m).Buying Opportunity • Feb 24Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ج.م0.37, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% per annum over the last 3 years. The company has become profitable over the last 3 years.Is New 90 Day High Low • Mar 16New 90-day high: ج.م1.06The company is up 121% from a price of ج.م0.48 on 16 December 2020. Outperformed the Egyptian market which is up 4.0% over the last 90 days. Exceeded the Packaging industry, which is up 31% over the same period.Reported Earnings • Mar 07Full year 2020 earnings released: EPS ج.م0.01 (vs ج.م0.017 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ج.م36.7m (up 23% from FY 2019). Net income: ج.م4.41m (down 21% from FY 2019). Profit margin: 12% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth.Is New 90 Day High Low • Feb 01New 90-day high: ج.م0.81The company is up 134% from its price of ج.م0.35 on 03 November 2020. The Egyptian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 36% over the same period.Is New 90 Day High Low • Jan 13New 90-day high: ج.م0.64The company is up 58% from its price of ج.م0.41 on 15 October 2020. The Egyptian market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 25% over the same period.Is New 90 Day High Low • Dec 17New 90-day high: ج.م0.53The company is up 14% from its price of ج.م0.46 on 17 September 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Packaging industry, which is up 26% over the same period.Is New 90 Day High Low • Nov 02New 90-day low: ج.م0.34The company is down 9.0% from its price of ج.م0.38 on 04 August 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Packaging industry, which is up 4.0% over the same period.お知らせ • Sep 17An unknown buyer acquired 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy for EGP 15.6 million.An unknown buyer acquired 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy for EGP 15.6 million on September 16, 2020. Wael Bebawy now holds 5.07% stake in Medical Packaging Company. An unknown buyer completed the acquisition of 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy on September 16, 2020.収支内訳Medical Packaging の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史CASE:MEPA 収益、費用、利益 ( )EGP Millions日付収益収益G+A経費研究開発費31 Mar 26981021031 Dec 251202420030 Sep 251343223030 Jun 251343718031 Mar 251334120031 Dec 241313719030 Sep 241324412030 Jun 241324212031 Mar 24120328031 Dec 2391218030 Sep 237097030 Jun 235226031 Mar 234906031 Dec 225964030 Sep 2256105030 Jun 225395031 Mar 225095031 Dec 214785030 Sep 214265030 Jun 214064031 Mar 213955031 Dec 203744030 Sep 203845030 Jun 203564031 Mar 203464031 Dec 193064030 Sep 192733030 Jun 192824031 Mar 192734031 Dec 182314030 Sep 182425030 Jun 1820-15031 Mar 1818-1311031 Dec 1723-1112030 Sep 1720-1111030 Jun 1719-1211031 Mar 1719-24031 Dec 1616-34030 Sep 1617-34030 Jun 1618-14031 Mar 1618-24031 Dec 1518-24030 Sep 1519-350質の高い収益: MEPAは 高品質の収益 を持っています。利益率の向上: MEPAの現在の純利益率 (10.6%)は、昨年(30.6%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: MEPAの収益は過去 5 年間で年間36.1%増加しました。成長の加速: MEPAは過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: MEPAは過去 1 年間で収益成長率がマイナス ( -74.5% ) となったため、 Packaging業界平均 ( -26.7% ) と比較することが困難です。株主資本利益率高いROE: MEPAの 自己資本利益率 ( 4.7% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/22 09:40終値2026/07/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Medical Packaging Company 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Aug 18Second quarter 2024 earnings released: EPS: ج.م0.021 (vs ج.م0.007 in 2Q 2023)Second quarter 2024 results: EPS: ج.م0.021 (up from ج.م0.007 in 2Q 2023). Revenue: ج.م29.0m (up 72% from 2Q 2023). Net income: ج.م13.8m (up 224% from 2Q 2023). Profit margin: 48% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 143% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 07Full year 2023 earnings released: EPS: ج.م0.032 (vs ج.م0.017 in FY 2022)Full year 2023 results: EPS: ج.م0.032. Revenue: ج.م91.0m (up 54% from FY 2022). Net income: ج.م2.10m (down 63% from FY 2022). Profit margin: 2.3% (down from 9.7% in FY 2022). The decrease in margin was driven by higher expenses.
Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ج.م7.00 (vs ج.م0.004 in 3Q 2021)Third quarter 2022 results: EPS: ج.م7.00 (up from ج.م0.004 in 3Q 2021). Revenue: ج.م15.5m (up 25% from 3Q 2021). Net income: ج.م2.37m (up 54% from 3Q 2021). Profit margin: 15% (up from 12% in 3Q 2021). The increase in margin was driven by higher revenue.
Reported Earnings • Mar 07Full year 2020 earnings released: EPS ج.م0.01 (vs ج.م0.017 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ج.م36.7m (up 23% from FY 2019). Net income: ج.م4.41m (down 21% from FY 2019). Profit margin: 12% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth.
New Risk • Jun 13New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 11% Last year net profit margin: 31% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (11% net profit margin). Revenue is less than US$5m (ج.م98m revenue, or US$1.9m). Market cap is less than US$100m (ج.م1.10b market cap, or US$21.2m).
お知らせ • Jun 02Medical Packaging Company, Annual General Meeting, Jun 20, 2026Medical Packaging Company, Annual General Meeting, Jun 20, 2026, at 12:00 Egypt Standard Time. Location: cairo Egypt
New Risk • May 22New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 25% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (25% accrual ratio). Minor Risks Revenue is less than US$5m (ج.م133m revenue, or US$2.7m). Market cap is less than US$100m (ج.م831.9m market cap, or US$16.7m).
お知らせ • Mar 20Medical Packaging Company, Annual General Meeting, Apr 12, 2025Medical Packaging Company, Annual General Meeting, Apr 12, 2025, at 13:00 Egypt Standard Time. Location: cairo Egypt
Reported Earnings • Aug 18Second quarter 2024 earnings released: EPS: ج.م0.021 (vs ج.م0.007 in 2Q 2023)Second quarter 2024 results: EPS: ج.م0.021 (up from ج.م0.007 in 2Q 2023). Revenue: ج.م29.0m (up 72% from 2Q 2023). Net income: ج.م13.8m (up 224% from 2Q 2023). Profit margin: 48% (up from 25% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 143% per year but the company’s share price has only increased by 35% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 24Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ج.م1.30, the stock trades at a trailing P/E ratio of 64.9x. Average trailing P/E is 6x in the Packaging industry in Africa. Total returns to shareholders of 169% over the past three years.
New Risk • Mar 31New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Egyptian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (13% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (2.3% net profit margin). Revenue is less than US$5m (ج.م91m revenue, or US$1.9m). Market cap is less than US$100m (ج.م1.47b market cap, or US$31.1m).
Reported Earnings • Mar 07Full year 2023 earnings released: EPS: ج.م0.032 (vs ج.م0.017 in FY 2022)Full year 2023 results: EPS: ج.م0.032. Revenue: ج.م91.0m (up 54% from FY 2022). Net income: ج.م2.10m (down 63% from FY 2022). Profit margin: 2.3% (down from 9.7% in FY 2022). The decrease in margin was driven by higher expenses.
Reported Earnings • Nov 18Third quarter 2022 earnings released: EPS: ج.م7.00 (vs ج.م0.004 in 3Q 2021)Third quarter 2022 results: EPS: ج.م7.00 (up from ج.م0.004 in 3Q 2021). Revenue: ج.م15.5m (up 25% from 3Q 2021). Net income: ج.م2.37m (up 54% from 3Q 2021). Profit margin: 15% (up from 12% in 3Q 2021). The increase in margin was driven by higher revenue.
New Risk • Nov 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Egyptian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2022 fiscal period end). Shareholders have been substantially diluted in the past year (90% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Revenue is less than US$5m (ج.م53m revenue, or US$1.7m). Market cap is less than US$100m (ج.م662.9m market cap, or US$21.5m).
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment improves as stock rises 41%After last week's 41% share price gain to ج.م1.01, the stock trades at a trailing P/E ratio of 75.3x. Average trailing P/E is 8x in the Packaging industry in Africa. Total returns to shareholders of 207% over the past three years.
Buying Opportunity • Oct 08Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 24%. The fair value is estimated to be ج.م0.80, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 32% over the last year. Earnings per share has grown by 47%.
New Risk • Aug 17New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended June 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported June 2022 fiscal period end). Share price has been highly volatile over the past 3 months (16% average weekly change). Shareholders have been substantially diluted in the past year (90% increase in shares outstanding). Minor Risks Revenue is less than US$5m (ج.م53m revenue, or US$1.7m). Market cap is less than US$100m (ج.م472.3m market cap, or US$15.3m).
Buying Opportunity • Feb 24Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 23%. The fair value is estimated to be ج.م0.37, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% per annum over the last 3 years. The company has become profitable over the last 3 years.
Is New 90 Day High Low • Mar 16New 90-day high: ج.م1.06The company is up 121% from a price of ج.م0.48 on 16 December 2020. Outperformed the Egyptian market which is up 4.0% over the last 90 days. Exceeded the Packaging industry, which is up 31% over the same period.
Reported Earnings • Mar 07Full year 2020 earnings released: EPS ج.م0.01 (vs ج.م0.017 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ج.م36.7m (up 23% from FY 2019). Net income: ج.م4.41m (down 21% from FY 2019). Profit margin: 12% (down from 19% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 70% per year, which means it is significantly lagging earnings growth.
Is New 90 Day High Low • Feb 01New 90-day high: ج.م0.81The company is up 134% from its price of ج.م0.35 on 03 November 2020. The Egyptian market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 36% over the same period.
Is New 90 Day High Low • Jan 13New 90-day high: ج.م0.64The company is up 58% from its price of ج.م0.41 on 15 October 2020. The Egyptian market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Packaging industry, which is up 25% over the same period.
Is New 90 Day High Low • Dec 17New 90-day high: ج.م0.53The company is up 14% from its price of ج.م0.46 on 17 September 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Packaging industry, which is up 26% over the same period.
Is New 90 Day High Low • Nov 02New 90-day low: ج.م0.34The company is down 9.0% from its price of ج.م0.38 on 04 August 2020. The Egyptian market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Packaging industry, which is up 4.0% over the same period.
お知らせ • Sep 17An unknown buyer acquired 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy for EGP 15.6 million.An unknown buyer acquired 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy for EGP 15.6 million on September 16, 2020. Wael Bebawy now holds 5.07% stake in Medical Packaging Company. An unknown buyer completed the acquisition of 11.4% stake in Medical Packaging Company (CASE:MEPA) from Wael Bebawy on September 16, 2020.